SCHEMBL9733599

SCHEMBL9733599

O=C(O)CCC(=O)c1cccc(F)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.61
NR4A2 P43354 1/20 0.46
ALDH1A1 P00352 3/20 0.45
KMT2A Q03164 3/20 0.45
CYP1A2 P05177 2/20 0.45
KDM4E B2RXH2 1/20 0.45
GLA P06280 1/20 0.45
POLB P06746 1/20 0.45
CYP2D6 P10635 1/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CTNNB1 P35222 5/20 0.44
WNT3A P56704 5/20 0.44
P2RX1 P51575 1/20 0.43
P2RX7 Q99572 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PTPN1 P18031 1/20 0.42
ERCC5 P28715 1/20 0.42
FEN1 P39748 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9733448 0.90 ALB (0.58) ALBHPGDCTNNB1WNT3AP2RX1
SCHEMBL7244500 0.83 CTNNB1 (0.60) NR4A2ALDH1A1KMT2ACYP1A2CTNNB1
SCHEMBL30758347 0.83 CTNNB1 (0.60) NR4A2ALDH1A1KMT2ACYP1A2CTNNB1
SCHEMBL1260174 0.82 ALB (0.56) ALBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL11635520 0.81 ALDH1A1 (0.51) NR4A2ALDH1A1KMT2ACYP1A2KDM4E
SCHEMBL14100100 0.79 MMP2 (0.61) NR4A2ALDH1A1KMT2ACYP1A2KDM4E
SCHEMBL11701099 0.79 NR4A2 (0.46) NR4A2ALDH1A1KMT2ACYP1A2KDM4E
SCHEMBL4598039 0.78 ALB (0.60) ALBALDH1A1KMT2AHSD17B10P2RX1
SCHEMBL2088179 0.77 CES2 (0.52) NR4A2ALDH1A1KMT2ACYP1A2KDM4E
SCHEMBL29499773 0.77 ALB (1.00) ALBALDH1A1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0156233-A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions MERCK & CO. INC. (US) 1985-10-02 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed